From: Evaluation of the impact of transient interruption of antiangiogenic treatment using ultrasound-based techniques in a murine model of hepatocellular carcinoma
Day +5
Day +11
%
Group 1 (Placebo)
20
0
30
50
10
40
Median values
15%
30%
Group 2 (Sor-Placebo-Sor)
10%
Group 3 (Sor-Placebo)
20%
5%
p = n.s.
p = 0.059